Zydus Lifesciences to Acquire Amplitude Surgical in €256.8 Million Transaction, To Delist Post-Acquisition

Zydus Lifesciences has signed exclusive talks to take over an 85.6% stake in French MedTech specialist Amplitude Surgical, which has lower-limb orthopedic technology as its focus area. The takeover deal is estimated at €256.8 million and involves buying shares at €6.25 apiece, a premium of 80.6% over the last close.

 

Major points:

 

 

Amplitude Surgical posted revenues of €106 million in FY24 and has been experiencing steady growth in orthopedics innovation. Dr. Sharvil Patel, Managing Director at Zydus, emphasized that the move is a natural extension into niche MedTech solutions.

 

The deal is anticipated to close by mid-2025, subject to regulatory clearances.

 

Source: Based on Zydus Lifesciences' regulatory filings, Business Upturn, and Amplitude Surgical's Press Release